BlackRock Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

BlackRock Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$510K	Buy	104,124 +1,207	+1%	+$7.25K	﹤0.01%	3043
2016 Q3	$797K	Sell	102,917 -4,676	-4%	-$31.5K	﹤0.01%	2808
2016 Q2	$603K	Buy	107,593 +6,259	+6%	+$40K	﹤0.01%	2954
2016 Q1	$545K	Buy	101,334 +1,714	+2%	+$9.96K	﹤0.01%	2864
2015 Q4	$868K	Buy	99,620 +220	+0.2%	+$1.86K	﹤0.01%	2701
2015 Q3	$834K	Sell	99,400 -1,147	-1%	-$18.3K	﹤0.01%	2729
2015 Q2	$1.77M	Buy	100,547 +96,694	+2,510%	+$1.24M	﹤0.01%	2336
2015 Q1	$45K	Buy	3,853 +58	+2%	+$671	﹤0.01%	3338
2014 Q4	$38K	Sell	3,795 -150	-4%	-$760	﹤0.01%	3375
2014 Q3	$18K	Buy	3,945 +186	+5%	+$999	﹤0.01%	3453
2014 Q2	$25K	Buy	+3,759	New	+$28.3K	﹤0.01%	3354

Other funds holding SRNE

Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return